Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(5 sites)
United States
University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina Levine Cancer Institute, Charlotte, North Carolina Duke Comprehensive Cancer Center, Durham, North Carolina Novant Health New Hanover Regional Medical Center, Wilmington, North Carolina The Ohio State University Comprehensive Cancer Center, Columbus, Ohio Age range
18 Years and older
Last updated September 2025